🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Organigram is pleased to announce its First Strategic U.S Investment in Phylos, a U.S. cannabis genetics company and developer of production-ready seeds. Press Release: bit.ly/43cbkgT

Organigram announces C$124.6M investment from BAT, deepening our strategic partnership. The majority of the investment will be used to accelerate Organigram’s global expansion ambitions in the rapidly evolving cannabis market. Press Release: bit.ly/3StTAep

Organigram is thrilled to announce its 2nd U.S. strategic investment! We've invested $2M in legal cannabinoid ingredients company, Open Book Extracts, harnessing Jupiter to accelerate our continued expansion into US and international markets. $OGI organigram.ca/press-releases…

From NB to NYC - Look at us Grow! Nasdaq Congratulates Organigram on Investment into U.S. Based Open Book Extracts $OGI

Great commentating here…

Interested in Germany's journey towards legalizing recreational cannabis? Check out insights from our CSO Paolo De Luca in this article recapping Cannabis Europa from MJBiz: mjbizdaily.com/can-germany-av… $OGI #cannabisindustry

Game-changer alert! Organigram's groundbreaking FAST™ nanoemulsion technology delivers quicker onset, enhanced bioavailability, and predictable effects. Get ready for the future of cannabis innovation. Read more here: organigram.ca/organigram-pro… $OGI #Organigram #cannabisindustry

We're proud to share our strong Q3 results, and excited for the road ahead! Read the details here: organigram.ca/sites/default/… #Organigram $OGI #cannabisindustry

Last night our CEO Beena Goldenberg joined BNN Bloomberg to discuss our strong earnings performance and what's next for $OGI. Tune in to hear insights on our most recent quarter including market expansion, as well as exciting innovations in the pipeline. Watch the full interview

Let's take a closer look and discover the benefits of our new FAST ™ nanoemulsion technology that will bring our edibles to the next level. Read more in our press release on the preliminary results of our extensive clinical trial, with the full report coming later this year

Legalizing cannabis aimed to eliminate the illegal market, but restrictive policies have kept it alive. In this opinion piece in the Financial Post, our CEO Beena Goldenberg explores the challenges for licensed producers are facing. $OGI #CannabisIndustry financialpost.com/opinion/govern…

Our brand new Edison Sonics gummies are here, powered by FAST™ nanoemulsion technology—clinically proven to deliver up to ~50% faster onset, improved bioavailability, and nearly double the cannabinoid delivery at peak effect $OGI organigram.ca/organigram-lau…

We are thrilled to announce that Organigram has officially acquired Motif, creating Canada’s largest licensed producer by market share. Motif is a leader in the manufacturing and commercialization of cannabis products, with leading positions in the vape and infused pre-roll

▶️🔥 Organigram Global $OGI CEO Beena Goldenberg was excited to share that after acquiring Motif Labs -- Organigram is now #1 by market share in 🇨🇦 Canada 🇨🇦🌎🥦🧺 $YOLO $MJ

Strong growth, improved margins, and market leadership—our Q4 fiscal 2024 highlights are in! Check out the full press release for all the details $OGI organigram.ca/press-releases…

We’re thrilled to announce the closing of the previously announced third tranche of the BAT Private Placement Investment. Read more: organigram.ca/organigram-clo… $OGI

LIVE Q&A: The OG Investor Session is still on, tune in now! zoom.us/j/97062761226?… $OGI

In response to growing consumer demand, Collective Project is now live in 25 U.S. states with a new DTC platform and a stacked lineup of hemp-derived THC drinks including sparkling juices, lemonades, and soon, THC sodas. Read more here: businesswire.com/news/home/2025… $OGI

Built to last. That’s not just a slogan — it’s a strategy. In an industry driven by short-term survival, the cannabis space often feels like a rollercoaster. Financial pressures and market volatility push companies to chase quarters instead of building moats.

The U.S. cannabis market isn’t one-size-fits-all. Paolo De Luca, CSO at Organigram Global, breaks down why success depends on mastering state by state strategies, adapting to complex regulations, and preparing for possible federal shifts. A must-listen for industry watchers.